A novel phosphatidylinositol 3-kinase (PI3K) inhibitor directs a potent FOXO-dependent, p53-independent cell cycle arrest phenotype characterized by the differential induction of a subset of FOXO-regulated genes

Authors

Wolfgang Link, University of Algarve
Richard Hill, University of Algarve
Ravi Kiran Reddy Kalathur, University of Algarve
Sergio Callejas, Centro Nacional de Investigaciones Cardiovasculares
Laura Colaço, University of Algarve
Ricardo Brandão, University of Algarve
Beatriz Serelde, Centro Nacional de Investigaciones Oncológicas
Antonio Cebriá, Centro Nacional de Investigaciones Oncológicas
Carmen Blanco-Aparicio, Centro Nacional de Investigaciones Oncológicas
Joaquín Pastor, Centro Nacional de Investigaciones Oncológicas
Matthias Futschik, School of Biomedical Sciences
Ana Dopazo, Centro Nacional de Investigaciones Cardiovasculares

ORCID

• Matthias Futschik: 0000-0002-6245-8071

DOI

10.1186/s13058-014-0482-y

Publication Date

2014-01-01

Publication Title

Breast Cancer Research

Volume

16

Issue

6

ISSN

1465-5411

Recommended Citation

Link, W., Hill, R., Kalathur, R., Callejas, S., Colaço, L., Brandão, R., Serelde, B., Cebriá, A., Blanco-Aparicio, C., Pastor, J., Futschik, M., & Dopazo, A. (2014) 'A novel phosphatidylinositol 3-kinase (PI3K) inhibitor directs a potent FOXO-dependent, p53-independent cell cycle arrest phenotype characterized by the differential induction of a subset of FOXO-regulated genes', Breast Cancer Research, 16(6). Available at: 10.1186/s13058-014-0482-y